View All Conferences
American Society of Clinical Oncology 2018
AI: The Future of Rare Disease Treatment?
Pauline Funchain MD, shares how artificial intelligence may serve as a potential breakthrough for treating rare diseases in the future.
Using Genomic Technology to Stratify Pediatric Cancer Patients
E. Anders Kolb, MD, discusses the exciting possibilities of using genomic technologies to stratify pediatric cancer patients.
Understanding Genetics to Develop Future Treatments for Rare Cancers
Pauline Funchain MD, explains how better understanding of genetics can help shape future treatments for rare cancers.
Challenges for Treating Patients with Rare Cancers
Manmeet Ahluwalia, MD, discusses the challenges patients and providers face when it comes to rare cancers.
Molecular Events, Not Time, Define Pediatric Oncology Outcomes
E. Anders Kolb, MD, outlines the challenges in diagnosing pediatric cancers and explains how molecular events define disease outcomes.
Metastatic Hepatocellular Carcinoma Treatment Receives Breakthrough Therapy Designation
The FDA has granted a breakthrough therapy for atezolizumab Tin combination with bevacizumab for the treatment of advanced or metastatic hepatocellular carcinoma.
New Drugs Needed to Target Pediatric Cancers
E. Anders Kolb, MD, emphasizes the difference between pediatric and adult cancers and the need to develop new treatments developed specifically for children.
Uncovering Rare Genetic Factors with Multiplex Germline Testing
Pauline Funchain, MD,
discusses the use of multiplex germline testing for rare diseases and cancers and explains the benefits of uncovering genetic factors.
The Pivotal Role of Clinical Trials in Lymphoma Treatments
Owen A. O’Connor, MD, PhD, outlines the importance of clinical trials and reviewed strides made in lymphoma treatments.
Exploring Use of Ibrutinib/Rituximab Combination for Waldenström Macroglobulinemia
Dr Meletios A. Dimopoulos, discusses the use of ibrutinib combined with rituximab for the treatment of patients with Waldenström macroglobulinemia.
Next Page >>
MOST POPULAR ARTICLES
Rare Pediatric Disease Designation Granted to Stargardt Disease Treatment, LBS-008
New Urine Diagnostic Test Offers Inexpensive Way to Detect Onchocerciasis
New Study Provides Hope for CADASIL Patients
Study Discovers Link Between Butterfly Syndrome and Skin Cancer
STRATEGIC ALLIANCE PARTNERSHIP PROGRAM >
Familial Chylomicronemia Syndrome
MJH ASSOCIATES >
Specialty Pharmacy Times
Terms & Conditions
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.